Multiply Labs Cuts Cell Therapy Manufacturing Costs 70% With Robotic Automation

Short summary

NVIDIA reports Multiply Labs is automating cell therapy manufacturing with robots, reducing costs by over 70%. The approach addresses a critical production bottleneck. Details are in NVIDIA's companion blog post.

• •Multiply Labs uses robotics to automate cell therapy manufacturing
• •Achieves cost reduction exceeding 70%
• •Targets key bottleneck in cell therapy production

Generated with AI, which can make mistakes.